Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling

Keyphrases

• Mouse Model 100%
• Methyl 100%
• Anxiolytic 100%
• Cannabinoid Signaling 100%
• Endogenous Cannabinoid 100%
• Pharmacological Evaluation 100%
• Cannabinoid Receptor Ligands 100%
• High Dose 50%
• Anxiety-like Behavior 50%
• Dose Effect 50%
• Cannabinoid Receptor Agonists 50%
• 1H-pyrazole 50%
• Pyrazole-3-carboxamides 50%
• Piperidin 50%
• Psychiatric Disorders 25%
• Adverse Effects 25%
• Drug Discovery 25%
• Catabolism 25%
• Δ9-tetrahydrocannabinol (Δ9-THC) 25%
• Locomotor Activity 25%
• Cannabis Sativa 25%
• Esters 25%
• Phenyl 25%
• Cannabinoid Receptor 1 (CB1R) 25%
• Pharmacological Modulation 25%
• Elevated Plus Maze 25%
• Endocannabinoids 25%
• Monophasic 25%
• CP55940 25%
• CB1 Receptor 25%
• Direct-acting 25%
• Pyrrol 25%
• Hydroxypropyl 25%
• Chlorophenyl 25%
• Open Arm 25%
• Sedative Effect 25%
• Cyclohexyl 25%
• Mesylate 25%
• Methanone 25%
• Carbamoyl 25%
• Anxiety-related Disorders 25%
• Morpholinyl 25%
• Biphenyl-3 25%
• Carbamic Acid 25%
• SR141716 25%
• Fatty Acid Amide Hydrolase Inhibitors 25%
• WIN55,212-2 25%
• CB1 Receptor Antagonist 25%
• AM251 25%
• Cannabinoid System 25%
• URB597 25%
• Endocannabinoid Uptake 25%
• AM404 25%
• Cannabinoid Receptor Antagonists 25%
• Calming Effect 25%
• Cyclohexan-1 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse Model 100%
• Endocannabinoid 100%
• Cannabinoid Receptor 100%
• Cannabinoid Receptor Agonist 40%
• Carboxamide 40%
• Pyrazole 40%
• Tetrahydrocannabinol 20%
• Methanesulfonic Acid 20%
• AM251 20%
• Cannabis Sativa 20%
• Drug Discovery 20%
• CP 55,940 20%
• Biphenyl 20%
• Cannabinoid 1 Receptor 20%
• Rimonabant 20%
• Carbamic Acid 20%
• Cannabinoid 1 Receptor Antagonist 20%
• Fatty Acid Amidase Inhibitor 20%
• Cannabinoid 1 Receptor Agonist 20%
• URB597 20%
• AM404 20%

Neuroscience

• Cannabinoid Receptor 100%
• Endocannabinoid 100%
• Receptor Agonists 40%
• Behavior (Neuroscience) 40%
• Carboxamide 40%
• Pyrazole 40%
• Locomotor Activity 20%
• Elevated Plus Maze 20%
• CB1 Receptor Antagonists 20%
• CB1 Receptor Agonist 20%
• Hydrolase Inhibitor 20%
• Adverse Effect 20%
• Mental Disorder 20%
• Receptor Antagonist 20%
• Cannabinoid 1 Receptor 20%
• CP 55,940 20%
• Biphenyl 20%
• Fatty Acid Amidase 20%
• AM404 20%
• Tetrahydrocannabinol 20%
• Cannabis Sativa 20%
• Rimonabant 20%
• AM251 20%